We are monitoring the impact of COVID-19 on Nuclear Medicine Radiopharmaceuticals Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 105
Share on
Share on

Global Nuclear Medicine Radiopharmaceuticals Market Analysis - By Diagnostics (SPECT, PET), By Therapeutics (Beta Emitters, Alpha Emitters, Brachytherapy), By Application (Cardiology, lymphoma, Thyroid, Neurology, Oncology) By Region - Industry Analysis, Size, Share, Growth, Trends, Forecast | 2019 – 2024

Pulished: August, 2019
ID: 105
Pages: 175

Nuclear Medicine Radiopharmaceuticals Market Size & Growth Rate (2019 - 2024)

The size of the Global Nuclear Medicine Radiopharmaceuticals market is estimated at $6.56 billion in 2019 and is expected to reach $12.3 billion by 2024, growing at a CAGR of 13.4%.

The rise in the incidences of cancer and cardiovascular diseases across the world is a major factor propelling the demand of the market. Growing disposable income in urban areas is ascribed to bolster the growth rate of the nuclear medicine radiopharmaceuticals market. Also, the growing prevalence of effective diagnostics and treatment procedures is making the demand for the market to move forward. Nuclear medicine plays an important role in the therapeutic applications of oncology, cardiology, neurology, and other applications and this attribute is leveling up the demand of the market. Besides, increasing expenditure on healthcare is driving the growth of the nuclear medicine radiopharmaceuticals market. An increasing number of targeted therapeutic procedures is gearing up the growth of the market.

However, stringent rules and regulations by the government in approving new products are slowly restraining the demand of the market. The dearth of skilled persons in utilizing various products of nuclear medicine for effective results is hampering the growth of the market. Some medicine requires huge amounts due to complex procedures is remained as a challenging factor for the market. Lack of standardization is also slightly inhibiting the growth rate of the market.

People's demand for early detection of diseases is likely to outshine the demand for the nuclear medicine radiopharmaceuticals market. 17.5 million people died from cardiovascular disease in 2012 according to WHO and it is to reach 23.3 million by 2030. The aforementioned attribute is greatly influencing the demand of the market. Increasing investments in the development of new medicines are elevating the growth of the market. Furthermore, the market is fuelled by growing knowledge over the availability of various techniques to treat various kinds of cancers.

Key happenings in this market in the recent past:

  • In 2013, the FDA approved the first and only alpha-emitter product on the market, launched by Bayer AG under the name Xofigo (Ra-223 dichloride molecule). The Ra-223 market in North America is expected to occupy the largest share, as it is a beta emitter targeted property and is the only alpha emitter product available on the market.
  • Other imaging modalities, including PET and MRI, continue to emerge as dominant players with expanded capabilities in diagnosing various heart conditions. Molecular imaging with novel radiopharmaceuticals designed to target specific intracellular processes can improve diagnostic accuracy and provide enhanced prognostic information to change management. O. O. Sogbein et al. reviewed recent advances in the development of radiotracers for SPECT and PET MPI, autonomic dysfunction, apoptosis, atherosclerotic plaque, metabolism, and viability. Related radiochemistry, preclinical and clinical development, and molecular imaging using new modalities such as cardiac MRI and PET-MR are also discussed.
  • Until recently, iodine-124 has not been considered to be an attractive isotope for medical applications due to an elaborate radioactive decay scheme involving several high-energy gamma rays. However, its unique chemistry and convenient half-life of 4.2 days indicate that it is only a matter of time before frequent use becomes a reality. Improvements in PET technology, including the development of new medical imaging technologies, especially new detectors and signal processing electronics, have opened up new perspectives for their applications. 

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Type, Application, Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation, Positron Corporation, Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and BA Molecular Imaging

 

This research report on the Global Nuclear Medicine Radiopharmaceuticals Market has been segmented and sub-segmented into the following categories

Nuclear Medicine Radiopharmaceuticals Market - By Type:

  • Diagnostic Radioisotopes                 
    • SPECT    
      • Technetium-99m
      • Thallium-201
      • Gallium-67
      • Iodine-23
      • Others
    • PET         
      • Fluorine-18
      • Rubidium-82
      • Others
  • Therapeutic Radioisotopes                              
    • Beta Emitters     
      • Iodine-131
      • Yttrium-90
      • Samarium-153
      • Rhenium-186
      • Lutetium-177
    • Alpha Emitters   
      • Radium-223
    • Brachytherapy   
      • Cesium-131
      • Iodine-125
      • Palladium-103
      • Iridium-192

Based on the type, the diagnostic radioisotopes segment is leading with the highest shares of the market. The emergence of the latest technologies in diagnostic centers is lavishing the growth of this segment to the extent. Increasing geriatric population and demand for quality diagnostic and treatment procedure at any cost is boosting up the growth of the nuclear medicine radiopharmaceuticals market.

Nuclear Medicine Radiopharmaceuticals Market - By Application:

  • Cardiology                               
  • Lymphoma                             
  • Thyroid                     
  • Neurology               
  • Oncology                 
  • Others           

Based on the application, the market is led by the Cardiology segment from the past few years and the Oncology sector is projected to grow at a faster rate in the coming years. An increasing number of patients visiting hospitals is promoting the demand of the market.    

Regional Analysis:

Regionally, North America is the dominant market for diagnostic radioisotopes. Within North America, the US is the largest consumer market for radioisotopes and Canada is the largest producer of Tc-99m. India and China hold a potential market for radioisotope due to rising healthcare and increasing demand for different radioisotopes in various treatments and applications.

Top companies in the market

Companies leading the Global Nuclear Medicine Radiopharmaceuticals Market profiled in the report are GE HealthcareHologic Inc., Medix Inc., Segami CorporationPositron CorporationBracco Imaging S.p.ANaviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and BA Molecular Imaging.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Analysis Design                                         

                2.3 Research Phases                                      

                                2.3.1 Secondary Research                            

                                2.3.2 Primary Research                 

                                2.3.3 Econometric Modelling                     

                                2.3.4 Expert Validation                  

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type                                        

                                5.1.1 Diagnostic Radioisotopes                 

                                                5.1.1.1 SPECT    

                                                                5.1.1.1.1 Technetium-99m

                                                                5.1.1.1.2 Thallium-201

                                                                5.1.1.1.3 Gallium-67

                                                                5.1.1.1.4 Iodine-23

                                                                5.1.1.1.5 Others

                                                5.1.1.2 PET         

                                                                5.1.1.2.1 Fluorine-18

                                                                5.1.1.2.2 Rubidium-82

                                                                5.1.1.2.3 Others

                                5.1.2 Therapeutic Radioisotopes                              

                                                5.1.2.1 Beta Emitters     

                                                                5.1.2.1.1 Iodine-131

                                                                5.1.2.1.2 Yttrium-90

                                                                5.1.2.1.3 Samarium-153

                                                                5.1.2.1.4 Rhenium-186

                                                                5.1.2.1.5 Lutetium-177

                                                5.1.2.2 Alpha Emitters   

                                                                5.1.2.2.1 Radium-223

                                                5.1.2.3 Brachytherapy   

                                                                5.1.2.3.1 Cesium-131

                                                                5.1.2.3.2 Iodine-125

                                                                5.1.2.3.3 Palladium-103

                                                                5.1.2.3.4 Iridium-192

                5.2 By Application                                           

                                5.2.1 Cardiology                               

                                5.2.2 Lymphoma                             

                                5.2.3 Thyroid                     

                                5.2.4 Neurology               

                                5.2.5 Oncology                 

                                5.2.6 Others                      

6. Geographical Analysis                                                              

                6.1 North America                                          

                                6.1.1 Introduction                           

                                6.1.2 United States                         

                                6.1.3 Canada                     

                6.2 Europe                                         

                                6.2.1 Introduction                           

                                6.2.2 U.K                             

                                6.2.3 Spain                         

                                6.2.4 Germany                 

                                6.2.5 Italy                           

                                6.2.6 France                      

                6.3 Asia-Pacific                                 

                                6.3.1 Introduction                           

                                6.3.2 China                         

                                6.3.3 India                          

                                6.3.4 Japan                        

                                6.3.5 South Korea                           

                6.4 Latin America                                            

                                6.4.1 Introduction                           

                                6.4.2 Brazil                         

                                6.4.3 Argentina                

                                6.4.4 Mexico                     

                6.5 Middle East & Africa                               

                                6.5.1 UAE                           

                                6.5.2 Saudi Arabia                           

                                6.5.3 Israel                         

                                6.5.4 South Africa                            

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8.Market Leaders' Analysis                                                          

                8.1 GE Healthcare                                           

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Hologic Inc.                                

                8.3 Segami Corporation                                

                8.4 Positron Corporation                                              

                8.5 Bracco Imaging S.P.A                                              

                8.6 Naviscan Inc.                                              

                8.7 Bayer Healthcare                                     

                8.8 Lantheus Medical Imaging Inc.                                           

                8.9 IBA Molecular Imaging                                           

                8.10 Medix Inc.                                

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10.Expert Opinions                                                         

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Nuclear Medicine Radiopharmaceuticals Market By Region, From 2019-2024 (USD Million)
  2. Global Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  3. Global Diagnostic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  4. Global Therapeutic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  5. Global Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  6. Global Cardiology Market By Region, From 2019-2024 (USD Million)
  7. Global Lymphoma Market By Region, From 2019-2024 (USD Million)
  8. Global Thyroid Market By Region, From 2019-2024 (USD Million)
  9. Global Neurology Market By Region, From 2019-2024 (USD Million)
  10. Global Oncology Market By Region, From 2019-2024 (USD Million)
  11. Global Other Applications Market By Region, From 2019-2024 (USD Million)
  12. Global Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  13. Global SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  14. Global PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  15. Global Other Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  16. Global SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  17. Global Technetium-99m Market By Region, From 2019-2024 ( USD Million )
  18. Global Thallium-201 Market By Region, From 2019-2024 ( USD Million )
  19. Global Gallium-67 Market By Region, From 2019-2024 ( USD Million )
  20. Global Iodine-23 Market By Region, From 2019-2024 ( USD Million )
  21. Global Other SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  22. Global PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  23. Global Fluorine-18 Market By Region, From 2019-2024 ( USD Million )
  24. Global Rubidium-82 Market By Region, From 2019-2024 ( USD Million )
  25. Global Other PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  26. Global Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  27. Global Beta Emitters Market By Region, From 2019-2024 ( USD Million )
  28. Global Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  29. Global Brachytherapy Market By Region, From 2019-2024 ( USD Million )
  30. Global Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  31. Global Iodine-131 Market By Region, From 2019-2024 ( USD Million )
  32. Global Yttrium-90 Market By Region, From 2019-2024 ( USD Million )
  33. Global Samarium-153 Market By Region, From 2019-2024 ( USD Million )
  34. Global Rhenium-186 Market By Region, From 2019-2024 ( USD Million )
  35. Global Lutetium-177 Market By Region, From 2019-2024 ( USD Million )
  36. Global Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  37. Global Radium-223 Market By Region, From 2019-2024 ( USD Million )
  38. Global Other Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  39. Global Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  40. Global Cesium-131 Market By Region, From 2019-2024 ( USD Million )
  41. Global Iodine-125 Market By Region, From 2019-2024 ( USD Million )
  42. Global Palladium-103 Market By Region, From 2019-2024 ( USD Million )
  43. Global Iridium-192 Market By Region, From 2019-2024 ( USD Million )
  44. North America Nuclear Medicine Radiopharmaceuticals Market By Region, From 2019-2024 (USD Million)
  45. North America Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  46. North America Diagnostic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  47. North America Therapeutic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  48. North America Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  49. North America Cardiology Market By Region, From 2019-2024 (USD Million)
  50. North America Lymphoma Market By Region, From 2019-2024 (USD Million)
  51. North America Thyroid Market By Region, From 2019-2024 (USD Million)
  52. North America Neurology Market By Region, From 2019-2024 (USD Million)
  53. North America Oncology Market By Region, From 2019-2024 (USD Million)
  54. North America Other Applications Market By Region, From 2019-2024 (USD Million)
  55. North America Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  56. North America SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  57. North America PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  58. North America Other Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  59. North America SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  60. North America Technetium-99m Market By Region, From 2019-2024 ( USD Million )
  61. North America Thallium-201 Market By Region, From 2019-2024 ( USD Million )
  62. North America Gallium-67 Market By Region, From 2019-2024 ( USD Million )
  63. North America Iodine-23 Market By Region, From 2019-2024 ( USD Million )
  64. North America Other SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  65. North America PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  66. North America Fluorine-18 Market By Region, From 2019-2024 ( USD Million )
  67. North America Rubidium-82 Market By Region, From 2019-2024 ( USD Million )
  68. North America Other PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  69. North America Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  70. North America Beta Emitters Market By Region, From 2019-2024 ( USD Million )
  71. North America Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  72. North America Brachytherapy Market By Region, From 2019-2024 ( USD Million )
  73. North America Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  74. North America Iodine-131 Market By Region, From 2019-2024 ( USD Million )
  75. North America Yttrium-90 Market By Region, From 2019-2024 ( USD Million )
  76. North America Samarium-153 Market By Region, From 2019-2024 ( USD Million )
  77. North America Rhenium-186 Market By Region, From 2019-2024 ( USD Million )
  78. North America Lutetium-177 Market By Region, From 2019-2024 ( USD Million )
  79. North America Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  80. North America Radium-223 Market By Region, From 2019-2024 ( USD Million )
  81. North America Other Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  82. North America Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  83. North America Cesium-131 Market By Region, From 2019-2024 ( USD Million )
  84. North America Iodine-125 Market By Region, From 2019-2024 ( USD Million )
  85. North America Palladium-103 Market By Region, From 2019-2024 ( USD Million )
  86. North America Iridium-192 Market By Region, From 2019-2024 ( USD Million )
  87. United States Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  88. United States Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  89. Canada Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  90. Canada Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  91. United States Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  92. Canada Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  93. United States SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  94. Canada SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  95. United States PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  96. Canada PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  97. United States Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  98. Canada Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  99. United States Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  100. Canada Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  101. United States Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  102. Canada Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  103. United States Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  104. Canada Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  105. Europe Nuclear Medicine Radiopharmaceuticals Market By Region, From 2019-2024 (USD Million)
  106. Europe Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  107. Europe Diagnostic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  108. Europe Therapeutic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  109. Europe Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  110. Europe Cardiology Market By Region, From 2019-2024 (USD Million)
  111. Europe Lymphoma Market By Region, From 2019-2024 (USD Million)
  112. Europe Thyroid Market By Region, From 2019-2024 (USD Million)
  113. Europe Neurology Market By Region, From 2019-2024 (USD Million)
  114. Europe Oncology Market By Region, From 2019-2024 (USD Million)
  115. Europe Other Applications Market By Region, From 2019-2024 (USD Million)
  116. Europe Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  117. Europe SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  118. Europe PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  119. Europe Other Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  120. Europe SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  121. Europe Technetium-99m Market By Region, From 2019-2024 ( USD Million )
  122. Europe Thallium-201 Market By Region, From 2019-2024 ( USD Million )
  123. Europe Gallium-67 Market By Region, From 2019-2024 ( USD Million )
  124. Europe Iodine-23 Market By Region, From 2019-2024 ( USD Million )
  125. Europe Other SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  126. Europe PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  127. Europe Fluorine-18 Market By Region, From 2019-2024 ( USD Million )
  128. Europe Rubidium-82 Market By Region, From 2019-2024 ( USD Million )
  129. Europe Other PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  130. Europe Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  131. Europe Beta Emitters Market By Region, From 2019-2024 ( USD Million )
  132. Europe Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  133. Europe Brachytherapy Market By Region, From 2019-2024 ( USD Million )
  134. Europe Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  135. Europe Iodine-131 Market By Region, From 2019-2024 ( USD Million )
  136. Europe Yttrium-90 Market By Region, From 2019-2024 ( USD Million )
  137. Europe Samarium-153 Market By Region, From 2019-2024 ( USD Million )
  138. Europe Rhenium-186 Market By Region, From 2019-2024 ( USD Million )
  139. Europe Lutetium-177 Market By Region, From 2019-2024 ( USD Million )
  140. Europe Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  141. Europe Radium-223 Market By Region, From 2019-2024 ( USD Million )
  142. Europe Other Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  143. Europe Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  144. Europe Cesium-131 Market By Region, From 2019-2024 ( USD Million )
  145. Europe Iodine-125 Market By Region, From 2019-2024 ( USD Million )
  146. Europe Palladium-103 Market By Region, From 2019-2024 ( USD Million )
  147. Europe Iridium-192 Market By Region, From 2019-2024 ( USD Million )
  148. U.K Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  149. U.K Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  150. Spain Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  151. Spain Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  152. Germany Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  153. Germany Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  154. Italy Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  155. Italy Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  156. France Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  157. France Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  158. U.K Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  159. Spain Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  160. Germany Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  161. Italy Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  162. France Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  163. U.K SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  164. Spain SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  165. Germany SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  166. Italy SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  167. France SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  168. U.K PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  169. Spain PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  170. Germany PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  171. Italy PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  172. France PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  173. U.K Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  174. Spain Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  175. Germany Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  176. Italy Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  177. France Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  178. U.K Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  179. Spain Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  180. Germany Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  181. Italy Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  182. France Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  183. U.K Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  184. Spain Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  185. Germany Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  186. Italy  Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  187. France Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  188. U.K Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  189. Spain Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  190. Germany Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  191. Italy Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  192. France Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  193. Asia-Pacific Nuclear Medicine Radiopharmaceuticals Market By Region, From 2019-2024 (USD Million)
  194. Asia-Pacific Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  195. Asia-Pacific Diagnostic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  196. Asia-Pacific Therapeutic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  197. Asia-Pacific Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  198. Asia-Pacific Cardiology Market By Region, From 2019-2024 (USD Million)
  199. Asia-Pacific Lymphoma Market By Region, From 2019-2024 (USD Million)
  200. Asia-Pacific Thyroid Market By Region, From 2019-2024 (USD Million)
  201. Asia-Pacific Neurology Market By Region, From 2019-2024 (USD Million)
  202. Asia-Pacific Oncology Market By Region, From 2019-2024 (USD Million)
  203. Asia-Pacific Other Applications Market By Region, From 2019-2024 (USD Million)
  204. Asia-Pacific Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  205. Asia-Pacific SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  206. Asia-Pacific PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  207. Asia-Pacific Other Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  208. Asia-Pacific SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  209. Asia-Pacific Technetium-99m Market By Region, From 2019-2024 ( USD Million )
  210. Asia-Pacific Thallium-201 Market By Region, From 2019-2024 ( USD Million )
  211. Asia-Pacific Gallium-67 Market By Region, From 2019-2024 ( USD Million )
  212. Asia-Pacific Iodine-23 Market By Region, From 2019-2024 ( USD Million )
  213. Asia-Pacific Other SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  214. Asia-Pacific PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  215. Asia-Pacific Fluorine-18 Market By Region, From 2019-2024 ( USD Million )
  216. Asia-Pacific Rubidium-82 Market By Region, From 2019-2024 ( USD Million )
  217. Asia-Pacific Other PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  218. Asia-Pacific Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  219. Asia-Pacific Beta Emitters Market By Region, From 2019-2024 ( USD Million )
  220. Asia-Pacific Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  221. Asia-Pacific Brachytherapy Market By Region, From 2019-2024 ( USD Million )
  222. Asia-Pacific Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  223. Asia-Pacific Iodine-131 Market By Region, From 2019-2024 ( USD Million )
  224. Asia-Pacific Yttrium-90 Market By Region, From 2019-2024 ( USD Million )
  225. Asia-Pacific Samarium-153 Market By Region, From 2019-2024 ( USD Million )
  226. Asia-Pacific Rhenium-186 Market By Region, From 2019-2024 ( USD Million )
  227. Asia-Pacific Lutetium-177 Market By Region, From 2019-2024 ( USD Million )
  228. Asia-Pacific Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  229. Asia-Pacific Radium-223 Market By Region, From 2019-2024 ( USD Million )
  230. Asia-Pacific Other Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  231. Asia-Pacific Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  232. Asia-Pacific Cesium-131 Market By Region, From 2019-2024 ( USD Million )
  233. Asia-Pacific Iodine-125 Market By Region, From 2019-2024 ( USD Million )
  234. Asia-Pacific Palladium-103 Market By Region, From 2019-2024 ( USD Million )
  235. Asia-Pacific Iridium-192 Market By Region, From 2019-2024 ( USD Million )
  236. China Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  237. China Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  238. India Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  239. India Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  240. Japan Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  241. Japan Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  242. South Korea Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  243. South Korea Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  244. China Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  245. India Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  246. Japan Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  247. South Korea Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  248. China SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  249. India SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  250. Japan SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  251. South Korea SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  252. China PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  253. India PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  254. Japan PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  255. South Korea PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  256. China Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  257. India Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  258. Japan Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  259. South Korea Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  260. China Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  261. India Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  262. Japan Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  263. South Korea Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  264. China Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  265. India Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  266. Japan Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  267. South Korea Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  268. China Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  269. India Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  270. Japan Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  271. South Korea Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  272. Latin America Nuclear Medicine Radiopharmaceuticals Market By Region, From 2019-2024 (USD Million)
  273. Latin America Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  274. Latin America Diagnostic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  275. Latin America Therapeutic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  276. Latin America Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  277. Latin America Cardiology Market By Region, From 2019-2024 (USD Million)
  278. Latin America Lymphoma Market By Region, From 2019-2024 (USD Million)
  279. Latin America Thyroid Market By Region, From 2019-2024 (USD Million)
  280. Latin America Neurology Market By Region, From 2019-2024 (USD Million)
  281. Latin America Oncology Market By Region, From 2019-2024 (USD Million)
  282. Latin America Other Applications Market By Region, From 2019-2024 (USD Million)
  283. Latin America Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  284. Latin America SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  285. Latin America PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  286. Latin America Other Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  287. Latin America SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  288. Latin America Technetium-99m Market By Region, From 2019-2024 ( USD Million )
  289. Latin America Thallium-201 Market By Region, From 2019-2024 ( USD Million )
  290. Latin America Gallium-67 Market By Region, From 2019-2024 ( USD Million )
  291. Latin America Iodine-23 Market By Region, From 2019-2024 ( USD Million )
  292. Latin America Other SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  293. Latin America PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  294. Latin America Fluorine-18 Market By Region, From 2019-2024 ( USD Million )
  295. Latin America Rubidium-82 Market By Region, From 2019-2024 ( USD Million )
  296. Latin America Other PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  297. Latin America Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  298. Latin America Beta Emitters Market By Region, From 2019-2024 ( USD Million )
  299. Latin America Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  300. Latin America Brachytherapy Market By Region, From 2019-2024 ( USD Million )
  301. Latin America Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  302. Latin America Iodine-131 Market By Region, From 2019-2024 ( USD Million )
  303. Latin America Yttrium-90 Market By Region, From 2019-2024 ( USD Million )
  304. Latin America Samarium-153 Market By Region, From 2019-2024 ( USD Million )
  305. Latin America Rhenium-186 Market By Region, From 2019-2024 ( USD Million )
  306. Latin America Lutetium-177 Market By Region, From 2019-2024 ( USD Million )
  307. Latin America Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  308. Latin America Radium-223 Market By Region, From 2019-2024 ( USD Million )
  309. Latin America Other Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  310. Latin America Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  311. Latin America Cesium-131 Market By Region, From 2019-2024 ( USD Million )
  312. Latin America Iodine-125 Market By Region, From 2019-2024 ( USD Million )
  313. Latin America Palladium-103 Market By Region, From 2019-2024 ( USD Million )
  314. Latin America Iridium-192 Market By Region, From 2019-2024 ( USD Million )
  315. Brazil Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  316. Brazil Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  317. Argentina Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  318. Argentina Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  319. Mexico Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  320. Mexico Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  321. Brazil Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  322. Argentina Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  323. Mexico Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  324. Brazil Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  325. Argentina Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  326. Mexico Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  327. Brazil SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  328. Argentina SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  329. Mexico SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  330. Brazil PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  331. Argentina PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  332. Mexico PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  333. Brazil Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  334. Argentina Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  335. Mexico Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  336. Brazil Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  337. Argentina Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  338. Mexico Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  339. Brazil Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  340. Argentina Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  341. Mexico Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  342. Brazil Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  343. Argentina Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  344. Mexico Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  345. Middle East & Africa Nuclear Medicine Radiopharmaceuticals Market By Region, From 2019-2024 (USD Million)
  346. Middle East & Africa Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  347. Middle East & Africa Diagnostic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  348. Middle East & Africa Therapeutic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  349. Middle East & Africa Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  350. Middle East & Africa Cardiology Market By Region, From 2019-2024 (USD Million)
  351. Middle East & Africa Lymphoma Market By Region, From 2019-2024 (USD Million)
  352. Middle East & Africa Thyroid Market By Region, From 2019-2024 (USD Million)
  353. Middle East & Africa Neurology Market By Region, From 2019-2024 (USD Million)
  354. Middle East & Africa Oncology Market By Region, From 2019-2024 (USD Million)
  355. Middle East & Africa Other Applications Market By Region, From 2019-2024 (USD Million)
  356. Middle East & Africa Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  357. Middle East & Africa SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  358. Middle East & Africa PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  359. Middle East & Africa Other Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  360. Middle East & Africa SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  361. Middle East & Africa Technetium-99m Market By Region, From 2019-2024 ( USD Million )
  362. Middle East & Africa Thallium-201 Market By Region, From 2019-2024 ( USD Million )
  363. Middle East & Africa Gallium-67 Market By Region, From 2019-2024 ( USD Million )
  364. Middle East & Africa Iodine-23 Market By Region, From 2019-2024 ( USD Million )
  365. Middle East & Africa Other SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  366. Middle East & Africa PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  367. Middle East & Africa Fluorine-18 Market By Region, From 2019-2024 ( USD Million )
  368. Middle East & Africa Rubidium-82 Market By Region, From 2019-2024 ( USD Million )
  369. Middle East & Africa Other PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  370. Middle East & Africa Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  371. Middle East & Africa Beta Emitters Market By Region, From 2019-2024 ( USD Million )
  372. Middle East & Africa Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  373. Middle East & Africa Brachytherapy Market By Region, From 2019-2024 ( USD Million )
  374. Middle East & Africa Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  375. Middle East & Africa Iodine-131 Market By Region, From 2019-2024 ( USD Million )
  376. Middle East & Africa Yttrium-90 Market By Region, From 2019-2024 ( USD Million )
  377. Middle East & Africa Samarium-153 Market By Region, From 2019-2024 ( USD Million )
  378. Middle East & Africa Rhenium-186 Market By Region, From 2019-2024 ( USD Million )
  379. Middle East & Africa Lutetium-177 Market By Region, From 2019-2024 ( USD Million )
  380. Middle East & Africa Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  381. Middle East & Africa Radium-223 Market By Region, From 2019-2024 ( USD Million )
  382. Middle East & Africa Other Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  383. Middle East & Africa Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  384. Middle East & Africa Cesium-131 Market By Region, From 2019-2024 ( USD Million )
  385. Middle East & Africa Iodine-125 Market By Region, From 2019-2024 ( USD Million )
  386. Middle East & Africa Palladium-103 Market By Region, From 2019-2024 ( USD Million )
  387. Middle East & Africa Iridium-192 Market By Region, From 2019-2024 ( USD Million )
  388. UAE Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  389. UAE Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  390. Saudi Arabia Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  391. Saudi Arabia Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  392. Israel Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  393. Israel Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  394. South Africa Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  395. South Africa Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  396. UAE Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  397. Saudi Arabia Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  398. Israel Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  399. South Africa Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  400. UAE SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  401. Saudi Arabia SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  402. Israel SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  403. South Africa SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  404. UAE PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  405. Saudi Arabia PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  406. Israel PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  407. South Africa PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  408. UAE Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  409. Saudi Arabia Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  410. Israel Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  411. South Africa Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  412. UAE Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  413. Saudi Arabia Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  414. Israel Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  415. South Africa Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  416. UAE Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  417. Saudi Arabia Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  418. Israel Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  419. South Africa Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  420. UAE Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  421. Saudi Arabia Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  422. Israel Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  423. South Africa Brachytherapy Market By Type, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample